Patents by Inventor Lixin Meng

Lixin Meng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12387040
    Abstract: The accuracy of existing machine learning models, software technologies, and computers are improved by using one or more machine learning models to predict a type of data that one or more numerical characters and/or one or more natural language word characters of a document correspond to. For instance, a Question Answering systems can be used to predict that a particular number value corresponds to a date, a billing amount, a page number, or the like.
    Type: Grant
    Filed: July 13, 2021
    Date of Patent: August 12, 2025
    Assignee: BILL Operations, LLC
    Inventors: Lixin Meng, Changlin Zhang, Sangammohan Harimohan Singh
  • Patent number: 12370179
    Abstract: Methods for treating obstructive hypertrophic cardiomyopathy are described herein. The treatment methods include the administration of a cardiac myosin inhibitor (CK-3773274, also referred to as CK-274 or aficamten) and may include titrating an administrated daily dose based on one or more components of an echocardiogram. The daily dose may be increased, maintained, decreased, or terminated, based on the echocardiogram.
    Type: Grant
    Filed: October 8, 2024
    Date of Patent: July 29, 2025
    Assignee: CYTOKINETICS, INC.
    Inventors: Fady Malik, Stuart Kupfer, Stephen B. Heitner, Laura Ann Robertson, Lixin Meng, Anna Osmukhina, Qi Wohltman
  • Publication number: 20250177357
    Abstract: Methods for treating obstructive hypertrophic cardiomyopathy are described herein. The treatment methods include the administration of a cardiac myosin inhibitor (CK-3773274, also referred to as CK-274 or aficamten) and may include titrating an administrated daily dose based on one or more components of an echocardiogram. The daily dose may be increased, maintained, decreased, or terminated, based on the echocardiogram.
    Type: Application
    Filed: October 15, 2024
    Publication date: June 5, 2025
    Inventors: Fady MALIK, Stuart KUPFER, Stephen B. HEITNER, Laura Ann ROBERTSON, Lixin MENG, Anna OSMUKHINA, Qi WOHLTMAN
  • Publication number: 20230058927
    Abstract: Methods for treating obstructive hypertrophic cardiomyopathy are described herein. The treatment methods include the administration of a cardiac myosin inhibitor (CK-3773274, also referred to as CK-274 or aficamten) and may include titrating an administrated daily dose based on one or more components of an echocardiogram. The daily dose may be increased, maintained, decreased, or terminated, based on the echocardiogram.
    Type: Application
    Filed: July 15, 2022
    Publication date: February 23, 2023
    Inventors: Fady MALIK, Stuart Kupfer, Stephen B. Heitner, Laura Ann Robertson, Lixin Meng, Anna Osmukhina, Qi Wohltman
  • Publication number: 20230022845
    Abstract: The accuracy of existing machine learning models, software technologies, and computers are improved by using one or more machine learning models to predict a type of data that one or more numerical characters and/or one or more natural language word characters of a document correspond to. For instance, a Question Answering systems can be used to predict that a particular number value corresponds to a date, a billing amount, a page number, or the like.
    Type: Application
    Filed: July 13, 2021
    Publication date: January 26, 2023
    Inventors: Lixin Meng, Changlin Zhang, Sangammohan Harimohan Singh
  • Publication number: 20140329754
    Abstract: This invention generally relates to compositions and methods for treating myelodysplastic syndrome. In one embodiment, this invention relates to methods for treating myelodysplastic syndrome with ezatiostat or a salt thereof and lenalidomide.
    Type: Application
    Filed: April 29, 2014
    Publication date: November 6, 2014
    Applicant: Telik, Inc.
    Inventors: Gail L. Brown, Lixin Meng
  • Patent number: 8759303
    Abstract: This invention generally relates to compositions and methods for treating myelodysplastic syndrome. In one embodiment, this invention relates to methods for treating myelodysplastic syndrome with ezatiostat or a salt thereof and lenalidomide.
    Type: Grant
    Filed: May 16, 2011
    Date of Patent: June 24, 2014
    Assignee: Telik, Inc.
    Inventors: Gail L. Brown, Lixin Meng
  • Publication number: 20110301199
    Abstract: This invention generally relates to compositions and methods for treating myelodysplastic syndrome. In one embodiment, this invention relates to methods for treating myelodysplastic syndrome with ezatiostat or a salt thereof in patients who have been treated with a DNA methyltransferase inhibitor by a combination of ezatiostat or a salt thereof and lenalidomide.
    Type: Application
    Filed: May 16, 2011
    Publication date: December 8, 2011
    Inventors: Gail L. Brown, Lixin Meng
  • Publication number: 20110301198
    Abstract: This invention generally relates to compositions and methods for treating myelodysplastic syndrome. In one embodiment, this invention relates to methods for treating myelodysplastic syndrome with ezatiostat or a salt thereof and lenalidomide.
    Type: Application
    Filed: May 16, 2011
    Publication date: December 8, 2011
    Inventors: Gail L. Brown, Lixin Meng